Sigma Labs Inc
NASDAQ:SGLB
Balance Sheet
Balance Sheet Decomposition
Sigma Labs Inc
Current Assets | 10.5m |
Cash & Short-Term Investments | 9.3m |
Receivables | 260k |
Other Current Assets | 950k |
Non-Current Assets | 1.3m |
PP&E | 290k |
Intangibles | 980k |
Other Non-Current Assets | -10k |
Current Liabilities | 900k |
Accounts Payable | 320k |
Accrued Liabilities | 420k |
Other Current Liabilities | 160k |
Balance Sheet
Sigma Labs Inc
Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
1
|
3
|
2
|
0
|
2
|
1
|
0
|
4
|
11
|
|
Cash |
0
|
1
|
3
|
2
|
0
|
2
|
1
|
0
|
4
|
11
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Assets |
0
|
1
|
3
|
2
|
1
|
3
|
2
|
1
|
5
|
13
|
|
PP&E Net |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
PP&E Gross |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Assets |
1
N/A
|
1
+106%
|
4
+193%
|
3
-23%
|
2
-41%
|
3
+81%
|
2
-28%
|
2
-30%
|
6
+237%
|
14
+143%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
0
|
1
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
0
N/A
|
0
+8%
|
0
+150%
|
0
-69%
|
1
+709%
|
0
-57%
|
1
+84%
|
1
+49%
|
1
-48%
|
1
+81%
|
|
Equity | |||||||||||
Common Stock |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Retained Earnings |
2
|
3
|
6
|
8
|
10
|
14
|
20
|
26
|
33
|
41
|
|
Additional Paid In Capital |
2
|
4
|
10
|
11
|
11
|
17
|
22
|
27
|
38
|
53
|
|
Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Equity |
1
N/A
|
1
+129%
|
4
+198%
|
3
-19%
|
1
-68%
|
3
+207%
|
2
-42%
|
1
-63%
|
5
+694%
|
13
+149%
|
|
Total Liabilities & Equity |
1
N/A
|
1
+106%
|
4
+193%
|
3
-23%
|
2
-41%
|
3
+81%
|
2
-28%
|
2
-30%
|
6
+237%
|
14
+143%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
6
|
11
|
|
Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|